Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Neck injection may restore swallowing in stroke survivors

NCT ID NCT06319534

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a nerve block called stellate ganglion block can improve swallowing in people with bulbar palsy after an ischemic stroke. 124 participants were randomly assigned to receive either standard rehabilitation alone or standard rehabilitation plus the nerve block. After 10 days, swallowing function was measured using video X-ray and other tools. The study is completed, and results may show whether this nerve block is a helpful addition to rehabilitation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
stellate ganglion block (a nerve block injection in the neck)
What this could lead to
If it works, this could offer a new way to improve swallowing for people with bulbar palsy after a stroke.
What could go wrong
This is a small, completed study with no phase designation, so results are preliminary. The nerve block procedure carries risks like bleeding, infection, or temporary nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

124 people

The number who actually took part.

Started

Mar 2024

Finished

Jul 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with ischemic stroke according to the diagnostic criteria, with the stroke occurring in the medulla oblongata and diagnosed as bulbar palsy. * Age \>18 years. * First-time stroke. * Steady vital signs, * Transferred or admitted to the Department of Rehabilitation Medicine within 15-30d after onset. * No cognitive impairment or aphasia, with the Montreal Cognitive Assessment score ≥21 points. * No history of severe mental illness or psychotropic drug dependence. * Unsafe or insufficient oral intake, indicating the need for enteral feeding Exclusion Criteria: * Contraindications for Stellate Ganglion Block.. * Structural abnormalities of the oropharynx. * Complicated with other neurological diseases. * Tracheostomy tube inserted. * Simultaneously suffering from liver, kidney failure, tumors, or hematological diseases. * Dysphagia caused by other possible diseases. * Pregnant females.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bulbar palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of rehabilitation medicine, the first ZU hospital north campus

    Zhenzhou, China

  • HLJ older people hospital

    Heilongjiang, China

  • Lankao Renmen Hospital

    Henan, China

  • NY zhongxin Hospital

    Naning, China

  • People's Hospital of SN tequ

    Suzhu, China

  • zhongshan affiliated No.1 Hospital

    Guandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.